These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
551 related articles for article (PubMed ID: 31163175)
1. Multiple functional therapeutic effects of DL-3-n-butylphthalide in the cuprizone model of demyelination. Wu Y; Dong L; Huang Q; Sun L; Liao Y; Tang Y; Wu Y Life Sci; 2019 Sep; 232():116501. PubMed ID: 31163175 [TBL] [Abstract][Full Text] [Related]
2. Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on Microglia. Nomura T; Bando Y; You H; Tanaka T; Yoshida S Neurochem Res; 2017 Dec; 42(12):3525-3536. PubMed ID: 28929408 [TBL] [Abstract][Full Text] [Related]
3. Protective and therapeutic role of Bilobalide in cuprizone-induced demyelination. Sui RX; Miao Q; Wang J; Wang Q; Song LJ; Yu JW; Cao L; Xiao W; Xiao BG; Ma CG Int Immunopharmacol; 2019 Jan; 66():69-81. PubMed ID: 30445309 [TBL] [Abstract][Full Text] [Related]
4. Unconventional Myosin ID is Involved in Remyelination After Cuprizone-Induced Demyelination. Yamazaki R; Baba H; Yamaguchi Y Neurochem Res; 2018 Jan; 43(1):195-204. PubMed ID: 28986688 [TBL] [Abstract][Full Text] [Related]
5. Prednisone alleviates demyelination through regulation of the NLRP3 inflammasome in a C57BL/6 mouse model of cuprizone-induced demyelination. Yu H; Wu M; Lu G; Cao T; Chen N; Zhang Y; Jiang Z; Fan H; Yao R Brain Res; 2018 Jan; 1678():75-84. PubMed ID: 29038005 [TBL] [Abstract][Full Text] [Related]
6. The flavonoid Baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation. Hashimoto M; Yamamoto S; Iwasa K; Yamashina K; Ishikawa M; Maruyama K; Bosetti F; Yoshikawa K Brain Res Bull; 2017 Oct; 135():47-52. PubMed ID: 28923306 [TBL] [Abstract][Full Text] [Related]
7. Restoration of FcRgamma/Fyn signaling repairs central nervous system demyelination. Seiwa C; Yamamoto M; Tanaka K; Fukutake M; Ueki T; Takeda S; Sakai R; Ishige A; Watanabe K; Akita M; Yagi T; Tanaka K; Asou H J Neurosci Res; 2007 Apr; 85(5):954-66. PubMed ID: 17290413 [TBL] [Abstract][Full Text] [Related]
8. Metformin Therapy Attenuates Pro-inflammatory Microglia by Inhibiting NF-κB in Cuprizone Demyelinating Mouse Model of Multiple Sclerosis. Abdi M; Pasbakhsh P; Shabani M; Nekoonam S; Sadeghi A; Fathi F; Abouzaripour M; Mohamed W; Zibara K; Kashani IR; Zendedel A Neurotox Res; 2021 Dec; 39(6):1732-1746. PubMed ID: 34570348 [TBL] [Abstract][Full Text] [Related]
9. Astrocyte-targeted production of interleukin-6 reduces astroglial and microglial activation in the cuprizone demyelination model: Implications for myelin clearance and oligodendrocyte maturation. Petković F; Campbell IL; Gonzalez B; Castellano B Glia; 2016 Dec; 64(12):2104-2119. PubMed ID: 27535761 [TBL] [Abstract][Full Text] [Related]
10. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination. Tanaka T; Murakami K; Bando Y; Yoshida S J Neurochem; 2013 Oct; 127(2):259-70. PubMed ID: 23647102 [TBL] [Abstract][Full Text] [Related]
11. Effect of the CSF1R inhibitor PLX3397 on remyelination of corpus callosum in a cuprizone-induced demyelination mouse model. Tahmasebi F; Pasbakhsh P; Mortezaee K; Madadi S; Barati S; Kashani IR J Cell Biochem; 2019 Jun; 120(6):10576-10586. PubMed ID: 30628737 [TBL] [Abstract][Full Text] [Related]
13. Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex. El-Etr M; Rame M; Boucher C; Ghoumari AM; Kumar N; Liere P; Pianos A; Schumacher M; Sitruk-Ware R Glia; 2015 Jan; 63(1):104-17. PubMed ID: 25092805 [TBL] [Abstract][Full Text] [Related]
14. Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model. Iwasa K; Yamamoto S; Takahashi M; Suzuki S; Yagishita S; Awaji T; Maruyama K; Yoshikawa K Prostaglandins Leukot Essent Fatty Acids; 2014 Nov; 91(5):175-82. PubMed ID: 25224839 [TBL] [Abstract][Full Text] [Related]
15. Functional Effects of Cuprizone-Induced Demyelination in the Presence of the mTOR-Inhibitor Rapamycin. Yamate-Morgan H; Lauderdale K; Horeczko J; Merchant U; Tiwari-Woodruff SK Neuroscience; 2019 May; 406():667-683. PubMed ID: 30703503 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of oligomeric proanthocyanidin in cuprizone-induced demyelination. Wang Q; Wang J; Yang Z; Sui R; Miao Q; Li Y; Yu J; Liu C; Zhang G; Xiao B; Ma C Exp Physiol; 2019 Jun; 104(6):876-886. PubMed ID: 30811744 [TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period. Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802 [TBL] [Abstract][Full Text] [Related]
18. The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination. Tomas-Roig J; Wirths O; Salinas-Riester G; Havemann-Reinecke U CNS Neurosci Ther; 2016 May; 22(5):387-95. PubMed ID: 26842941 [TBL] [Abstract][Full Text] [Related]
19. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination. Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706 [TBL] [Abstract][Full Text] [Related]
20. Auraptene induces oligodendrocyte lineage precursor cells in a cuprizone-induced animal model of demyelination. Nakajima M; Shimizu R; Furuta K; Sugino M; Watanabe T; Aoki R; Okuyama S; Furukawa Y Brain Res; 2016 May; 1639():28-37. PubMed ID: 26944297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]